Samsung Galaxy devices could feature vision and language-assisted task automation.
In this week’s featured patent applications, we cover the latest from Samsung, Microsoft, Apple, IBM, Merck, Boston Scientific, Novartis, Roche, Abbott, and Medtronic.
Samsung Files a Patent for an Apparatus for Vision and Language-Assisted Smartphone Task Automation
U.S. patent application, US20200285353, discloses a Programming-by-Demonstration (PBD) system that leverages vision and language algorithms to enable a smartphone user to create and execute an automation script for arbitrary tasks. The user may perform a sequence of actions in a task that may be captured by the smartphone and saved as an automation script for future use.
Microsoft Seeks a Patent for Natural Quick Function Gestures
U.S. patent application, US20200285806, describes a method to interact with a spreadsheet document using a variety of touch-based gestures for making structural and display changes to the spreadsheet and for navigating to various parts of the spreadsheet. The figure below illustrates natural gestures for interacting with spreadsheet documents.
Apple Pursues Patents for Attention Aware Virtual Assistant Dismissal
U.S. application, US20200285327, discloses a method for operating an intelligent automated assistant in an energy efficient manner by automatically deactivating the assistant when a user becomes disinterested, as illustrated below.
IBM Files a Patent Application Related to Locomotion in Virtual Reality (VR) Desk Applications
U.S. patent application, US20200285304, discloses a VR system that allows a user to move in a VR environment while sitting in front of a working desk. The VR system generates sitting motion data by interpreting sensor data received from a mobile device and maps the motion data into a set of movements in the VR environment. The figures below illustrate the VR system in which the user’s motions are used to drive the locomotion in the VR environment.
Boston Scientific Seeks a Patent for a Cerebral Vasculature Protection System
U.S. patent application, US20200281708, discloses a blood-filtering assembly that captures embolic materials dislodged or generated during an endovascular procedure, to inhibit or prevent the materials from entering the cerebral vasculature. The figure below illustrates the cerebral vascular protection assembly.
Merck Files a Patent for Image Processing of Webpages
U.S. patent application, US20200285918, discloses a web detection system, which processes webpage information and performs automated feature extraction of web pages. The web detection system determines a subset of web pages having a target characteristic by processing markup language. When the web detection system determines that images overlap, it generates an image of a web page such that the portion of the second image is obscured by the first image and determines a graphical feature of the webpage by processing the image (e.g. using optical character recognition). The figure below illustrates a mockup of a webpage.
Roche Seeks a Patent for Autonomous Management of a Diabetic Condition Based on Mealtime and Activity Detection
U.S. patent application, US20200286612, discloses a method that includes determining a score based on activity and mealtime detection indicators like location, position, blood glucose level, and providing an alert based on a score associated with the indicators. The figure below depicts an environment for monitoring/treating a diabetic condition.
Novartis Pursues a Patent for the Treatment of Cancer Using Chimeric Antigen Receptors
U.S. patent application, US20200283729, discusses a method for the treatment of cancer through the parenteral administration of a chimeric antigen receptor (CAR) molecule, in combination with an agent. The CAR molecule further comprises an antigen-binding domain, a transmembrane domain, and an intracellular domain.
Abbott Files a Patent Application for a Target Nucleic Acid Detection Composition
U.S. patent application, US20200283822, discloses a system for detecting a target nucleic acid in a sample. The detection involves the interaction of a target nucleic acid with one oligonucleotide to produce a signal DNA, which initiates production of cascade signal amplifier DNAs to reach the desired amplification.
Medtronic Wants a Patent for a Position-Sensitive Lingual Muscle Simulation System for Obstructive Sleep Apnea (OSA) Treatment
U.S. patent application, US20200282219, discloses an implantable neurostimulator (INS) having an electrical lead with bipolar electrodes placed proximate to the lingual muscles of the patient’s tongue. Electrical energy is delivered to the electrodes when the INS orientation correlates to a posture in which the patient experiences obstructive sleep apnea. The figure below illustrates the INS.